Literature DB >> 17617765

Mechanisms of cardiac fibrosis in hypertension.

Javier Díez1.   

Abstract

Changes in the composition of cardiac tissue develop in hypertensive patients with left ventricular hypertrophy (ie, hypertensive heart disease) and lead to structural remodeling of the myocardium. One of these changes is related to the disruption of the equilibrium between the synthesis and degradation of collagen types I and III molecules, which results in an excessive accumulation of collagen types I and III fibers within the myocardium. Myocardial fibrosis is the consequence of a number of pathologic processes mediated by mechanical, neurohormonal, and cytokine routes. The clinical relevance of fibrosis is that it may contribute to heart failure and other cardiac complications in patients with hypertensive heart disease. This brief review focuses on the mechanisms of hypertensive myocardial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617765      PMCID: PMC8110048          DOI: 10.1111/j.1524-6175.2007.06626.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  42 in total

Review 1.  Cardiovascular changes in chronic renal failure--pathogenesis and therapy.

Authors:  K Amann; K Tyralla
Journal:  Clin Nephrol       Date:  2002-07       Impact factor: 0.975

Review 2.  Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations.

Authors:  A P Sappino; W Schürch; G Gabbiani
Journal:  Lab Invest       Date:  1990-08       Impact factor: 5.662

3.  Contractile cells in rat myocardial scar tissue.

Authors:  R Vracko; D Thorning
Journal:  Lab Invest       Date:  1991-08       Impact factor: 5.662

4.  Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure.

Authors:  Begoña López; Arantxa González; Ramón Querejeta; Mariano Larman; Javier Díez
Journal:  J Am Coll Cardiol       Date:  2006-06-12       Impact factor: 24.094

5.  Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.

Authors:  C G Brilla; R C Funck; H Rupp
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

6.  Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease.

Authors:  B Schwartzkopff; M Brehm; M Mundhenke; B E Strauer
Journal:  Hypertension       Date:  2000-08       Impact factor: 10.190

7.  Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans.

Authors:  M A Rossi
Journal:  J Hypertens       Date:  1998-07       Impact factor: 4.844

Review 8.  Gender differences in older patients with pressure-overload hypertrophy of the left ventricle.

Authors:  G P Aurigemma; W H Gaasch
Journal:  Cardiology       Date:  1995       Impact factor: 1.869

Review 9.  The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy.

Authors:  Juan Asbun; Francisco J Villarreal
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

10.  Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1).

Authors:  Stephan Rosenkranz; Markus Flesch; Kerstin Amann; Claudia Haeuseler; Heiko Kilter; Ute Seeland; Klaus-Dieter Schlüter; Michael Böhm
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09       Impact factor: 4.733

View more
  58 in total

Review 1.  Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise?

Authors:  Thijs M H Eijsvogels; Antonio B Fernandez; Paul D Thompson
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy.

Authors:  Cadie L Buckley; Alexander J Stokes
Journal:  Channels (Austin)       Date:  2011-07-01       Impact factor: 2.581

3.  Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.

Authors:  Barbara Gürtl; Dagmar Kratky; Christian Guelly; Lefeng Zhang; Gregor Gorkiewicz; Suman Kumar Das; Kuppusamy Palaniappan Tamilarasan; Gerald Hoefler
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

Review 4.  Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease.

Authors:  Nicholas C Bene; Pilar Alcaide; Henry H Wortis; Iris Z Jaffe
Journal:  Steroids       Date:  2014-04-21       Impact factor: 2.668

5.  Small dedifferentiated cardiomyocytes bordering on microdomains of fibrosis: evidence for reverse remodeling with assisted recovery.

Authors:  Fahed Al Darazi; Wenyuan Zhao; Tieqiang Zhao; Yao Sun; Tony N Marion; Robert A Ahokas; Syamal K Bhattacharya; Ivan C Gerling; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2014-09       Impact factor: 3.105

Review 6.  Connecting sex differences, estrogen signaling, and microRNAs in cardiac fibrosis.

Authors:  Lejla Medzikovic; Laila Aryan; Mansoureh Eghbali
Journal:  J Mol Med (Berl)       Date:  2019-08-26       Impact factor: 4.599

7.  Serum concentration of procollagen type III amino-terminal peptide is increased in patients with successfully repaired coarctation of the aorta with left ventricular hypertrophy.

Authors:  Hirokuni Yamazawa; Tomoaki Murakami; Atsuhito Takeda; Kouta Takei; Takuo Furukawa; Hiromichi Nakajima
Journal:  Pediatr Cardiol       Date:  2014-10-14       Impact factor: 1.655

8.  Regional Strain Analysis with Multidetector CT in a Swine Cardiomyopathy Model: Relationship to Cardiac MR Tagging and Myocardial Fibrosis.

Authors:  Michael W Tee; Samuel Won; Fabio S Raman; Colin Yi; Davis M Vigneault; Cynthia Davies-Venn; Songtao Liu; Albert C Lardo; João A C Lima; J Alison Noble; Craig A Emter; David A Bluemke
Journal:  Radiology       Date:  2015-04-08       Impact factor: 11.105

9.  Fibronectin in aging extracellular matrix fibrils is progressively unfolded by cells and elicits an enhanced rigidity response.

Authors:  Meher Antia; Gretchen Baneyx; Kristopher E Kubow; Viola Vogel
Journal:  Faraday Discuss       Date:  2008       Impact factor: 4.008

10.  Hypertension increases with aging and obesity in chimpanzees (Pan troglodytes).

Authors:  John J Ely; Tony Zavaskis; Michael L Lammey
Journal:  Zoo Biol       Date:  2012-09-11       Impact factor: 1.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.